Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Iksuda Therapeutics

Iksuda to Present IKS014 Phase 1 Data at ESMO
From Iksuda Therapeutics
Via Business Wire
Iksuda Therapeutics Receives FDA IND Clearance for IKS014
From Iksuda Therapeutics
Via Business Wire
Iksuda Therapeutics announces first patient successfully dosed in phase 1 trial evaluating IKS03 in advanced B cell non-Hodgkin lymphomas
From Iksuda Therapeutics
Via Business Wire
Iksuda to Present Growing ADC Pipeline at AACR
From Iksuda Therapeutics
Via Business Wire
Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2
From Iksuda Therapeutics
Via Business Wire
Iksuda Therapeutics Deepens Clinical Pipeline Through Licensing Agreement for Her2 Antibody Drug Conjugate Programme From LegoChem Biosciences
From Iksuda Therapeutics
Via Business Wire
LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates
From Iksuda Therapeutics
Via Business Wire
Iksuda Therapeutics Closes $47 Million Financing Round
From Iksuda Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.